2015-07-16

[DIV28SUPER] NIDA Neuroscience Update, July 17, 2015

Table of Contents

 

I.     Scholarships Available for Short Course on the Genetics of Addiction August 24- 30, 2015, Bar Harbor, ME!

http://courses.jax.org/2015/addiction.html

 

II.     First Annual NIDA-NIAAA Early Career Investigator Showcase Friday, October 16, 5:00 PM – 6:00 PM McCormick Place Convention Center Chicago, IL http://apps1.seiservices.com/ecisabstracts/

 

III.    Reissue:  NIDA's Cutting-Edge Basic Research Awards (CEBRA) (R21) http://grants.nih.gov/grants/guide/pa-files/PAR-15-079.html

 

IV.    Harnessing Genome Editing Technologies to Functioning Validate Genetic Variants in Substance Use Disorders (R21/R33) RFA-DA-16-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

 

V.     Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)  PAR-15-120 http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf Next due date: Oct. 20, 2015



 

  

I.      Scholarships Available for Short Course on the Genetics of Addiction August 24- 30, 2015, Bar Harbor, ME!

http://courses.jax.org/2015/addiction.html

 

Scholarship requests must be received by July 24th

 

This course emphasizes genetic applications and approaches to drug addiction research through methodological instruction based on literature, data sets and informatics resources drawn from studies of addiction related phenotypes. The course includes plenary sessions on major progress in addiction genetics, and discussion sessions in which students present their work for discussion on applications of genetic methods. Students will leave the course able to design and interpret genetic and genomic studies of addiction as they relate to their specific research question, and will be able to make use of current bioinformatics resources to identify research resources and make use of public data sources in their own research.

 

Scholarships may be available to help attendees with travel expenses.  Please indicate on your application form if you are requesting a scholarship.  Scholarship applications must include a letter of recommendation from your supervisor or mentor that indicates your financial need.  All scholarship requests must be received by July 24th.

 

Funding for this conference was made possible (in part) by R13 DA 032192 from the National Institute on Drug Abuse. These views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


 

 

II.     First Annual NIDA-NIAAA Early Career Investigator Showcase Friday, October 16, 5:00 PM – 6:00 PM McCormick Place Convention Center Chicago, IL http://apps1.seiservices.com/ecisabstracts/

 

Application due date July 31, 2015

 

The National Institute on Drug Abuse [NIDA] and the National Institute on Alcohol Abuse and Alcoholism
[NIAAA] are co-sponsoring a symposium, Early Career Investigator Showcase [ECIS], as a satellite event to the 2015 Annual Meeting of the Society for Neuroscience [SfN], Chicago, IL. The ECIS symposium provides a forum for scientific presentations by premier young and junior investigators working in the fields of substance abuse and addiction research. The theme for this year's ECIS symposium is the consequences of drug and alcohol abuse on development. This symposium will take place on Friday, 16 October 2015, from 5:00 – 6:00 pm at the McCormick Place Convention Center (tentative) immediately following the 2015 Joint NIDA-NIAAA Frontiers in Addiction Research Mini-Convention.

NIDA and NIAAA are now soliciting applications from investigators to participate in the ECIS symposium. To be eligible for consideration, the applicant must currently have an individual postdoctoral fellowship Ruth L. Kirschstein National Research Service Award [F32], a mentored career development award [K01, K08, K23,K99], or grant support as a NIH New Investigator/Early Stage Investigator [http://grants.nih.gov/grants/new_investigators/]. A $1000 travel award will be given to each of the six (6) individuals selected for this symposium to be applied towards expenses incurred for travel to this event. Individuals selected for ECIS will be chosen for the quality of their research, its impact in the field, and its relevance to the mission of NIDA or NIAAA. Applications are due by Friday, 31 July 2015, 5:00 PM (EDT). For an application and additional information, please go to http://apps1.seiservices.com/ecisabstracts/ or contact: for NIDA [Roger Sorensen, rsorense@mail.nih.gov]; or for NIAAA [Antonio Noronha, anoronha@mail.nih.gov].

 

 

III.    Reissue:  NIDA's Cutting-Edge Basic Research Awards (CEBRA) (R21) http://grants.nih.gov/grants/guide/pa-files/PAR-15-079.html

 

Next Application due date Aug 20, 2015

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them. It supports research that is high-risk and potentially high-impact that is underrepresented or not included in NIDA's current portfolio. The proposed research should: (1) test a highly novel and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would have a substantial impact on current thinking; and/or (2) develop or adapt innovative techniques or methods for addiction research, or that have promising future applicability to drug abuse research. 

Contact:

Susan Volman, Ph.D.
National Institute on Drug Abuse
Telephone: 301-435-1315
Email: svolman@mail.nih.gov

 

 

IV.    Harnessing Genome Editing Technologies to Functioning Validate Genetic Variants in Substance Use Disorders (R21/R33) RFA-DA-16-004 http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

 

Application due date Aug 25, 2015

 

Funding Opportunity Purpose

The purpose of this initiative is to harness genome or epigenome editing technologies to functionally validate and characterize genetic or epigenetic variants involved in substance use disorders.  The purpose is also that the genetic resources generated will be made broadly available to the scientific community to probe more deeply into the neurobiological mechanisms involved in the function of a variant, gene, or pathway and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.

Please see full announcement for details. http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-16-004.html

Scientific/Research Contact(s):

 

John Satterlee, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: satterleej@nida.nih.gov

 

V.      Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)  PAR-15-120 http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

 

Next application due date: Oct. 20, 2015

 

 The goals of this initiative are to identify gene variants of traits associated with addiction and substance abuse in selectively bred, and outbred  non-human animal models using methodologies of Next Gen-Sequencing, mapping, and genotyping. See more information at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-120.html#sthash.bBPhto89.dpuf

Contact:

 

Jonathan D. Pollock, Ph.D.

Chief

Genetics and Molecular Neurobiology Research Branch

Division of Basic Neurobiology and Behavioral Research

National Institute on Drug Abuse, NIH

6001 Executive Blvd, Rm. 4257

Bethesda, MD 20892

Tel. 301-435-1309

Email. jpollock@mail.nih.gov

 

 

 ------------------------------------------------------


The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contactjpollock@mail.nih.gov     301-435-1309

No comments:

Post a Comment